Rank | Gene Set | Z-score |
---|---|---|
1 | protein localization to cilium (GO:0061512) | 9.60876248 |
2 | left/right pattern formation (GO:0060972) | 9.26246144 |
3 | protein polyglutamylation (GO:0018095) | 8.24844303 |
4 | regulation of female gonad development (GO:2000194) | 8.05474288 |
5 | primary alcohol catabolic process (GO:0034310) | 7.33762751 |
6 | regulation of cilium movement (GO:0003352) | 7.24695952 |
7 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 7.03807744 |
8 | vitamin transmembrane transport (GO:0035461) | 6.98745957 |
9 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 6.40789152 |
10 | ethanol metabolic process (GO:0006067) | 6.10469733 |
11 | cilium organization (GO:0044782) | 5.99811011 |
12 | activation of protein kinase A activity (GO:0034199) | 5.83551791 |
13 | response to xenobiotic stimulus (GO:0009410) | 5.75095164 |
14 | microtubule severing (GO:0051013) | 5.62633564 |
15 | axonemal dynein complex assembly (GO:0070286) | 5.57671733 |
16 | centriole assembly (GO:0098534) | 5.55153511 |
17 | diterpenoid biosynthetic process (GO:0016102) | 5.53253702 |
18 | tolerance induction (GO:0002507) | 5.29414305 |
19 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 5.27614714 |
20 | regulation of interleukin-5 production (GO:0032674) | 5.26277605 |
21 | intraciliary transport (GO:0042073) | 5.15401815 |
22 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 5.10709807 |
23 | cAMP biosynthetic process (GO:0006171) | 5.06448912 |
24 | cilium movement (GO:0003341) | 5.00204830 |
25 | behavioral response to cocaine (GO:0048148) | 4.95014422 |
26 | dopamine receptor signaling pathway (GO:0007212) | 4.86143236 |
27 | microtubule-based movement (GO:0007018) | 4.85637215 |
28 | lung epithelium development (GO:0060428) | 4.78359645 |
29 | cilium morphogenesis (GO:0060271) | 4.77724158 |
30 | one-carbon compound transport (GO:0019755) | 4.73943564 |
31 | sperm capacitation (GO:0048240) | 4.73508575 |
32 | establishment of apical/basal cell polarity (GO:0035089) | 4.71382900 |
33 | negative regulation of B cell mediated immunity (GO:0002713) | 4.66172548 |
34 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 4.66172548 |
35 | glomerular epithelial cell development (GO:0072310) | 4.63573839 |
36 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 4.63473004 |
37 | negative regulation of T cell differentiation in thymus (GO:0033085) | 4.62312654 |
38 | cellular component assembly involved in morphogenesis (GO:0010927) | 4.59951259 |
39 | regulation of interleukin-13 production (GO:0032656) | 4.57640506 |
40 | ethanol oxidation (GO:0006069) | 4.44458520 |
41 | axoneme assembly (GO:0035082) | 4.40702988 |
42 | regulation of microtubule-based movement (GO:0060632) | 4.40674191 |
43 | ventricular system development (GO:0021591) | 4.39161238 |
44 | negative regulation of humoral immune response (GO:0002921) | 4.39115251 |
45 | regulation of germinal center formation (GO:0002634) | 4.23682282 |
46 | cell projection assembly (GO:0030031) | 4.20988235 |
47 | regulation of synapse structural plasticity (GO:0051823) | 4.17229225 |
48 | positive regulation of tolerance induction (GO:0002645) | 4.15638011 |
49 | response to gravity (GO:0009629) | 4.07416654 |
50 | antibacterial humoral response (GO:0019731) | 4.06131552 |
51 | establishment of monopolar cell polarity (GO:0061162) | 4.05813969 |
52 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 4.05813969 |
53 | response to caffeine (GO:0031000) | 4.05705483 |
54 | regulation of protein kinase A signaling (GO:0010738) | 3.98128965 |
55 | negative regulation of inclusion body assembly (GO:0090084) | 3.91308007 |
56 | retinoic acid metabolic process (GO:0042573) | 3.88766539 |
57 | cytoplasmic microtubule organization (GO:0031122) | 3.87610339 |
58 | adipose tissue development (GO:0060612) | 3.86937236 |
59 | microtubule depolymerization (GO:0007019) | 3.85012650 |
60 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 3.82800108 |
61 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 3.82800108 |
62 | cellular response to glucagon stimulus (GO:0071377) | 3.80573658 |
63 | terpenoid biosynthetic process (GO:0016114) | 3.80074414 |
64 | regulation of chromatin binding (GO:0035561) | 3.79033125 |
65 | neuron cell-cell adhesion (GO:0007158) | 3.73086219 |
66 | antimicrobial humoral response (GO:0019730) | 3.72281444 |
67 | lateral ventricle development (GO:0021670) | 3.67453495 |
68 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 3.67276971 |
69 | microtubule polymerization or depolymerization (GO:0031109) | 3.64900310 |
70 | innate immune response in mucosa (GO:0002227) | 3.59921299 |
71 | detection of calcium ion (GO:0005513) | 3.57511027 |
72 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.47026801 |
73 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.45882997 |
74 | magnesium ion transport (GO:0015693) | 3.42749489 |
75 | response to amphetamine (GO:0001975) | 3.38986486 |
76 | atrial cardiac muscle cell action potential (GO:0086014) | 3.34931601 |
77 | peptidyl-glutamic acid modification (GO:0018200) | 3.32589287 |
78 | centriole replication (GO:0007099) | 3.29294394 |
79 | auditory receptor cell differentiation (GO:0042491) | 3.28903544 |
80 | auditory behavior (GO:0031223) | 3.28638992 |
81 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 3.27968854 |
82 | O-glycan processing (GO:0016266) | 3.27605968 |
83 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 3.26347978 |
84 | cAMP metabolic process (GO:0046058) | 3.26131748 |
85 | exogenous drug catabolic process (GO:0042738) | 3.25616084 |
86 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.25613848 |
87 | establishment of planar polarity (GO:0001736) | 3.23534303 |
88 | establishment of tissue polarity (GO:0007164) | 3.23534303 |
89 | regulation of sodium ion transmembrane transport (GO:1902305) | 3.19525398 |
90 | response to inactivity (GO:0014854) | 3.18865140 |
91 | primary alcohol metabolic process (GO:0034308) | 3.18717929 |
92 | left/right axis specification (GO:0070986) | 3.17583791 |
93 | sperm motility (GO:0030317) | 3.17195392 |
94 | peristalsis (GO:0030432) | 3.16671726 |
95 | regulation of tolerance induction (GO:0002643) | 3.16162579 |
96 | positive regulation of growth hormone secretion (GO:0060124) | 3.14736087 |
97 | glutathione derivative metabolic process (GO:1901685) | 3.13258468 |
98 | glutathione derivative biosynthetic process (GO:1901687) | 3.13258468 |
99 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 3.11498918 |
100 | positive regulation of smoothened signaling pathway (GO:0045880) | 3.10946249 |
101 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.10384887 |
102 | fibroblast migration (GO:0010761) | 3.09011020 |
103 | adenylate cyclase-activating G-protein coupled receptor signaling pathway (GO:0007189) | 3.06641605 |
104 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 3.06176968 |
105 | mucosal immune response (GO:0002385) | 3.06018424 |
106 | potassium ion homeostasis (GO:0055075) | 3.04756756 |
107 | regulation of microtubule depolymerization (GO:0031114) | 3.04478137 |
108 | potassium ion export (GO:0071435) | 3.04447063 |
109 | retinol metabolic process (GO:0042572) | 3.01959863 |
110 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.00791243 |
111 | regulation of sodium ion transport (GO:0002028) | 3.00411455 |
112 | * sensory perception of smell (GO:0007608) | 22.5623362 |
113 | response to glucagon (GO:0033762) | 2.99054882 |
114 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 2.97760206 |
115 | glutamate secretion (GO:0014047) | 2.97750280 |
116 | determination of left/right symmetry (GO:0007368) | 2.97170383 |
117 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.95811474 |
118 | regulation of neurotransmitter uptake (GO:0051580) | 2.93391801 |
119 | striatum development (GO:0021756) | 2.90793229 |
120 | positive regulation of neurotransmitter transport (GO:0051590) | 2.90541793 |
121 | apical protein localization (GO:0045176) | 2.89130599 |
122 | axonal fasciculation (GO:0007413) | 2.88895526 |
123 | organ or tissue specific immune response (GO:0002251) | 2.87718518 |
124 | cardiac conduction (GO:0061337) | 2.87038792 |
125 | cellular copper ion homeostasis (GO:0006878) | 2.86260989 |
126 | determination of bilateral symmetry (GO:0009855) | 2.86114398 |
127 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.85490174 |
128 | microtubule bundle formation (GO:0001578) | 2.85069027 |
129 | microtubule-based process (GO:0007017) | 2.84661213 |
130 | specification of symmetry (GO:0009799) | 2.80085132 |
131 | * cellular potassium ion transport (GO:0071804) | 2.78916599 |
132 | * potassium ion transmembrane transport (GO:0071805) | 2.78916599 |
133 | aldehyde catabolic process (GO:0046185) | 2.77922553 |
134 | nucleoside diphosphate phosphorylation (GO:0006165) | 2.77782795 |
135 | carnitine metabolic process (GO:0009437) | 2.76383371 |
136 | reactive oxygen species biosynthetic process (GO:1903409) | 2.75542515 |
137 | behavioral response to ethanol (GO:0048149) | 2.74959058 |
138 | olfactory bulb development (GO:0021772) | 2.74654163 |
139 | neuroblast proliferation (GO:0007405) | 2.73199807 |
140 | membrane repolarization during action potential (GO:0086011) | 2.71768205 |
141 | epithelial cilium movement (GO:0003351) | 2.71514497 |
142 | phosphatidylcholine biosynthetic process (GO:0006656) | 2.70872998 |
143 | negative regulation of circadian rhythm (GO:0042754) | 2.69970929 |
144 | mating behavior (GO:0007617) | 2.68112230 |
145 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway (GO:0007193) | 2.66978360 |
146 | connective tissue development (GO:0061448) | 2.63271173 |
147 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.61848137 |
148 | organelle assembly (GO:0070925) | 2.61497451 |
149 | smoothened signaling pathway (GO:0007224) | 2.61406327 |
150 | diol metabolic process (GO:0034311) | 2.60993973 |
151 | multicellular organismal water homeostasis (GO:0050891) | 2.60593529 |
152 | negative regulation of microtubule polymerization (GO:0031115) | 2.60315427 |
153 | lateral sprouting from an epithelium (GO:0060601) | 2.60249780 |
154 | chemical homeostasis within a tissue (GO:0048875) | 2.58980447 |
155 | excretion (GO:0007588) | 2.57648759 |
156 | negative regulation of astrocyte differentiation (GO:0048712) | 2.57076864 |
157 | regulation of RIG-I signaling pathway (GO:0039535) | 2.55637855 |
158 | single fertilization (GO:0007338) | 2.54846107 |
159 | cilium assembly (GO:0042384) | 2.54566594 |
160 | cellular response to leptin stimulus (GO:0044320) | 2.54523868 |
161 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 2.54201707 |
162 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.54047092 |
163 | water transport (GO:0006833) | 2.53984548 |
164 | hypotonic response (GO:0006971) | 2.53753632 |
165 | regulation of response to osmotic stress (GO:0047484) | 2.53624202 |
166 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.52157112 |
167 | regulation of autophagic vacuole assembly (GO:2000785) | 2.51887713 |
168 | drug catabolic process (GO:0042737) | 2.50350008 |
169 | negative regulation of microtubule depolymerization (GO:0007026) | 2.47769024 |
170 | regulation of inclusion body assembly (GO:0090083) | 2.45123176 |
171 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.44984095 |
172 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 2.44586130 |
173 | progesterone metabolic process (GO:0042448) | 2.44423892 |
174 | hydrogen peroxide catabolic process (GO:0042744) | 2.40742274 |
175 | regulation of apoptotic cell clearance (GO:2000425) | 2.39634646 |
176 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 2.37799934 |
177 | CDP-diacylglycerol metabolic process (GO:0046341) | 2.37314423 |
178 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.37038345 |
179 | cilium or flagellum-dependent cell motility (GO:0001539) | 18.7361376 |
180 | motile cilium assembly (GO:0044458) | 15.1677054 |
181 | * sensory perception of chemical stimulus (GO:0007606) | 12.6976877 |
182 | protein insertion into membrane (GO:0051205) | 11.6647719 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.62336483 |
2 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 5.19310522 |
3 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.83788684 |
4 | TAF15_26573619_Chip-Seq_HEK293_Human | 3.36028777 |
5 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 3.31765120 |
6 | ZNF263_19887448_ChIP-Seq_K562_Human | 3.23040735 |
7 | DROSHA_22980978_ChIP-Seq_HELA_Human | 3.04059326 |
8 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.88605596 |
9 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.88459317 |
10 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.36624278 |
11 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.34865605 |
12 | STAT1_20625510_ChIP-Seq_HELA_Human | 2.10905731 |
13 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 2.09705111 |
14 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.97752175 |
15 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.97383911 |
16 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.95684745 |
17 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.93225686 |
18 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.91772524 |
19 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.90671441 |
20 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.88702338 |
21 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.88702338 |
22 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.87264128 |
23 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.82790688 |
24 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.81563064 |
25 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.79544504 |
26 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.75031389 |
27 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.74645259 |
28 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.73919947 |
29 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.73210911 |
30 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.72152392 |
31 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.70044461 |
32 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.66560948 |
33 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.66321262 |
34 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.65084307 |
35 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.63178702 |
36 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.62477586 |
37 | GATA1_19941826_ChIP-Seq_K562_Human | 1.62388834 |
38 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.60347971 |
39 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.60335430 |
40 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.58881293 |
41 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.57901188 |
42 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.57393388 |
43 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.56141294 |
44 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.52776853 |
45 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.52732158 |
46 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.51979501 |
47 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.51833324 |
48 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.51739850 |
49 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.51312479 |
50 | VDR_22108803_ChIP-Seq_LS180_Human | 1.51155454 |
51 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.50662431 |
52 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.50224020 |
53 | KDM2B_26808549_Chip-Seq_K562_Human | 1.48781190 |
54 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.48666954 |
55 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.48144882 |
56 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.47032289 |
57 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.46787805 |
58 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.44922341 |
59 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.44810856 |
60 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.43354576 |
61 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.41664615 |
62 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.40123552 |
63 | ETV1_20927104_ChIP-Seq_GIST48_Human | 1.39498293 |
64 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.39470741 |
65 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.37614113 |
66 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.37134056 |
67 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.36699797 |
68 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.36588953 |
69 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.36306446 |
70 | * GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.35971220 |
71 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.35481984 |
72 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.34680614 |
73 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.34501665 |
74 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.34429620 |
75 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.32794333 |
76 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.32794333 |
77 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.32269275 |
78 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.31312212 |
79 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 1.30773590 |
80 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.30068439 |
81 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.28648669 |
82 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.28596755 |
83 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.28495598 |
84 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.27658247 |
85 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.26153720 |
86 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 1.26040880 |
87 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.25539599 |
88 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.25262279 |
89 | P300_19829295_ChIP-Seq_ESCs_Human | 1.24446441 |
90 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.23496589 |
91 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.23083351 |
92 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.22952574 |
93 | P68_20966046_ChIP-Seq_HELA_Human | 1.22438247 |
94 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.21816521 |
95 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.20906998 |
96 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.20159424 |
97 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.19551850 |
98 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.18738657 |
99 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.18432701 |
100 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.18201434 |
101 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.17200964 |
102 | RBPJ_21746931_ChIP-Seq_IB4_Human | 1.17152166 |
103 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.17057873 |
104 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.16604496 |
105 | * ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.16291126 |
106 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.15607964 |
107 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.14351297 |
108 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.14281069 |
109 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.14233777 |
110 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.12761651 |
111 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.12516010 |
112 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.12140703 |
113 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.11788985 |
114 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.11282253 |
115 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.09816709 |
116 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.09375019 |
117 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.09247034 |
118 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.08734874 |
119 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.08536064 |
120 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.08414478 |
121 | GATA2_19941826_ChIP-Seq_K562_Human | 1.08302091 |
122 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.07336856 |
123 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 1.06988895 |
124 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.06481069 |
125 | * CTCF_20526341_ChIP-Seq_ESCs_Human | 1.06258417 |
126 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05426183 |
127 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 1.03895774 |
128 | NFYA_21822215_ChIP-Seq_K562_Human | 1.03712810 |
129 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.03655248 |
130 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.03510427 |
131 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.03332778 |
132 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.03078126 |
133 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 1.02968561 |
134 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 1.02809756 |
135 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.02687472 |
136 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.02542157 |
137 | P300_27268052_Chip-Seq_Bcells_Human | 1.01700541 |
138 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.01618502 |
139 | SOX2_21211035_ChIP-Seq_LN229_Human | 1.00835219 |
140 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 1.00683915 |
141 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.00366860 |
142 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.99985489 |
143 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.99878378 |
144 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99566969 |
145 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.99292130 |
146 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.98975616 |
147 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.97008214 |
148 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.96476075 |
149 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.96386628 |
150 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.96131975 |
151 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.95898068 |
152 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.95402021 |
153 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.94798391 |
154 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.94377197 |
155 | NFYB_21822215_ChIP-Seq_K562_Human | 0.94130775 |
156 | TBL1_22424771_ChIP-Seq_293T_Human | 0.92739636 |
157 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 0.92634670 |
158 | GATA3_21867929_ChIP-Seq_TH1_Mouse | 0.91178682 |
159 | FLI1_21867929_ChIP-Seq_CD8_Mouse | 0.91059114 |
160 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.90973746 |
161 | * SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.90972583 |
162 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.90730535 |
163 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.90723189 |
164 | STAT3_23295773_ChIP-Seq_U87_Human | 0.90585652 |
165 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.89253188 |
166 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.88753095 |
167 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.88681600 |
168 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 0.88636056 |
169 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 0.88554787 |
170 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.88548198 |
171 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.88503523 |
172 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.88419338 |
173 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.88002359 |
174 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.87450500 |
175 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.86777584 |
176 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.86140778 |
177 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.85767286 |
178 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.85683539 |
179 | NCOR_22424771_ChIP-Seq_293T_Human | 0.85543078 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002132_abnormal_respiratory_system | 6.47649138 |
2 | MP0002277_abnormal_respiratory_mucosa | 4.34275152 |
3 | MP0008789_abnormal_olfactory_epithelium | 4.07723178 |
4 | MP0005499_abnormal_olfactory_system | 3.95261537 |
5 | MP0005394_taste/olfaction_phenotype | 3.95261537 |
6 | MP0004043_abnormal_pH_regulation | 3.62928996 |
7 | MP0002822_catalepsy | 3.51896444 |
8 | MP0009780_abnormal_chondrocyte_physiolo | 3.48621909 |
9 | MP0003806_abnormal_nucleotide_metabolis | 2.83478289 |
10 | MP0002184_abnormal_innervation | 2.61291325 |
11 | MP0000566_synostosis | 2.40826542 |
12 | MP0002168_other_aberrant_phenotype | 2.30234586 |
13 | MP0000383_abnormal_hair_follicle | 2.26168249 |
14 | MP0003880_abnormal_central_pattern | 2.25773842 |
15 | MP0003136_yellow_coat_color | 2.16586590 |
16 | MP0004019_abnormal_vitamin_homeostasis | 2.06664850 |
17 | MP0001485_abnormal_pinna_reflex | 2.03368467 |
18 | * MP0001984_abnormal_olfaction | 15.0355990 |
19 | MP0003656_abnormal_erythrocyte_physiolo | 1.96534778 |
20 | MP0010678_abnormal_skin_adnexa | 1.90200509 |
21 | MP0002282_abnormal_trachea_morphology | 1.87060444 |
22 | MP0000516_abnormal_urinary_system | 1.84672719 |
23 | MP0005367_renal/urinary_system_phenotyp | 1.84672719 |
24 | MP0001765_abnormal_ion_homeostasis | 1.78400150 |
25 | MP0005084_abnormal_gallbladder_morpholo | 1.77904897 |
26 | MP0003890_abnormal_embryonic-extraembry | 1.65394282 |
27 | MP0005083_abnormal_biliary_tract | 1.60318801 |
28 | MP0002909_abnormal_adrenal_gland | 1.59904113 |
29 | MP0002653_abnormal_ependyma_morphology | 1.55675196 |
30 | MP0002734_abnormal_mechanical_nocicepti | 1.54954896 |
31 | MP0002928_abnormal_bile_duct | 1.54804782 |
32 | MP0000678_abnormal_parathyroid_gland | 1.53745600 |
33 | MP0005645_abnormal_hypothalamus_physiol | 1.46934830 |
34 | MP0005395_other_phenotype | 1.45697696 |
35 | MP0001188_hyperpigmentation | 1.42061829 |
36 | MP0005410_abnormal_fertilization | 1.40187611 |
37 | MP0003252_abnormal_bile_duct | 1.40124129 |
38 | MP0003635_abnormal_synaptic_transmissio | 1.39824991 |
39 | MP0005646_abnormal_pituitary_gland | 1.34286249 |
40 | MP0002752_abnormal_somatic_nervous | 1.33363916 |
41 | MP0001486_abnormal_startle_reflex | 1.31000256 |
42 | MP0002272_abnormal_nervous_system | 1.29858327 |
43 | MP0004859_abnormal_synaptic_plasticity | 1.26613890 |
44 | MP0002557_abnormal_social/conspecific_i | 1.23548130 |
45 | MP0010155_abnormal_intestine_physiology | 1.22567252 |
46 | MP0001346_abnormal_lacrimal_gland | 1.15144888 |
47 | MP0001929_abnormal_gametogenesis | 1.14883235 |
48 | MP0005636_abnormal_mineral_homeostasis | 1.12558620 |
49 | MP0010234_abnormal_vibrissa_follicle | 1.11980627 |
50 | MP0002877_abnormal_melanocyte_morpholog | 1.10890079 |
51 | MP0001529_abnormal_vocalization | 1.10262607 |
52 | MP0008875_abnormal_xenobiotic_pharmacok | 1.10069131 |
53 | MP0003698_abnormal_male_reproductive | 1.09498221 |
54 | MP0002249_abnormal_larynx_morphology | 1.08846272 |
55 | MP0002160_abnormal_reproductive_system | 1.08091164 |
56 | MP0005365_abnormal_bile_salt | 1.06947989 |
57 | MP0002233_abnormal_nose_morphology | 1.04932751 |
58 | MP0002882_abnormal_neuron_morphology | 1.04122534 |
59 | MP0002063_abnormal_learning/memory/cond | 1.03930420 |
60 | MP0004270_analgesia | 1.03017641 |
61 | MP0005248_abnormal_Harderian_gland | 1.00796105 |
62 | MP0000465_gastrointestinal_hemorrhage | 1.00445055 |
63 | MP0003303_peritoneal_inflammation | 0.99436082 |
64 | MP0000778_abnormal_nervous_system | 0.98983185 |
65 | MP0003045_fibrosis | 0.98757885 |
66 | MP0005409_darkened_coat_color | 0.97497986 |
67 | MP0001542_abnormal_bone_strength | 0.93421283 |
68 | MP0004811_abnormal_neuron_physiology | 0.92094739 |
69 | MP0008004_abnormal_stomach_pH | 0.88686223 |
70 | MP0005058_abnormal_lysosome_morphology | 0.85628789 |
71 | MP0004145_abnormal_muscle_electrophysio | 0.85289526 |
72 | MP0003942_abnormal_urinary_system | 0.85101137 |
73 | MP0001970_abnormal_pain_threshold | 0.84996740 |
74 | MP0005085_abnormal_gallbladder_physiolo | 0.84120121 |
75 | MP0000681_abnormal_thyroid_gland | 0.83669387 |
76 | MP0002572_abnormal_emotion/affect_behav | 0.82072539 |
77 | MP0004264_abnormal_extraembryonic_tissu | 0.81095422 |
78 | MP0002152_abnormal_brain_morphology | 0.80074916 |
79 | MP0010030_abnormal_orbit_morphology | 0.77924997 |
80 | MP0004133_heterotaxia | 0.76711496 |
81 | MP0002064_seizures | 0.76148350 |
82 | MP0002136_abnormal_kidney_physiology | 0.76133626 |
83 | MP0009643_abnormal_urine_homeostasis | 0.75627125 |
84 | MP0003879_abnormal_hair_cell | 0.75236124 |
85 | MP0003453_abnormal_keratinocyte_physiol | 0.74598004 |
86 | MP0001849_ear_inflammation | 0.74076690 |
87 | MP0005623_abnormal_meninges_morphology | 0.73700041 |
88 | MP0009053_abnormal_anal_canal | 0.71778282 |
89 | MP0003075_altered_response_to | 0.71720795 |
90 | MP0006276_abnormal_autonomic_nervous | 0.71245681 |
91 | MP0005387_immune_system_phenotype | 0.70710567 |
92 | MP0001790_abnormal_immune_system | 0.70710567 |
93 | MP0005164_abnormal_response_to | 0.69782175 |
94 | MP0002405_respiratory_system_inflammati | 0.68307544 |
95 | MP0008874_decreased_physiological_sensi | 0.67893389 |
96 | MP0003634_abnormal_glial_cell | 0.67890328 |
97 | MP0005220_abnormal_exocrine_pancreas | 0.67679548 |
98 | MP0004883_abnormal_blood_vessel | 0.67284097 |
99 | MP0009745_abnormal_behavioral_response | 0.66634285 |
100 | MP0005408_hypopigmentation | 0.63529094 |
101 | MP0005165_increased_susceptibility_to | 0.63020896 |
102 | MP0000631_abnormal_neuroendocrine_gland | 0.62809031 |
103 | MP0005551_abnormal_eye_electrophysiolog | 0.61957497 |
104 | MP0009763_increased_sensitivity_to | 0.61132465 |
105 | MP0000538_abnormal_urinary_bladder | 0.60508078 |
106 | MP0000049_abnormal_middle_ear | 0.60379924 |
107 | MP0003878_abnormal_ear_physiology | 0.60174376 |
108 | MP0005377_hearing/vestibular/ear_phenot | 0.60174376 |
109 | MP0005423_abnormal_somatic_nervous | 0.59889920 |
110 | MP0000372_irregular_coat_pigmentation | 0.59776547 |
111 | MP0009379_abnormal_foot_pigmentation | 0.59505930 |
112 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.59254887 |
113 | MP0001324_abnormal_eye_pigmentation | 0.58951017 |
114 | MP0002139_abnormal_hepatobiliary_system | 0.58400376 |
115 | MP0002161_abnormal_fertility/fecundity | 0.58309298 |
116 | MP0002067_abnormal_sensory_capabilities | 0.58058192 |
117 | MP0005310_abnormal_salivary_gland | 0.56726232 |
118 | MP0002638_abnormal_pupillary_reflex | 0.55282448 |
119 | MP0004510_myositis | 0.55154963 |
120 | MP0000534_abnormal_ureter_morphology | 0.54663514 |
121 | MP0005171_absent_coat_pigmentation | 0.52931943 |
122 | MP0002229_neurodegeneration | 0.51505876 |
123 | MP0009046_muscle_twitch | 0.51362271 |
124 | MP0003633_abnormal_nervous_system | 0.51225133 |
125 | MP0002084_abnormal_developmental_patter | 0.50895283 |
126 | MP0009703_decreased_birth_body | 0.50859063 |
127 | MP0005389_reproductive_system_phenotype | 0.50739394 |
128 | MP0000026_abnormal_inner_ear | 0.48348282 |
129 | MP0002098_abnormal_vibrissa_morphology | 0.48195478 |
130 | MP0006036_abnormal_mitochondrial_physio | 0.47953258 |
131 | MP0001664_abnormal_digestion | 0.47681154 |
132 | MP0009333_abnormal_splenocyte_physiolog | 0.47110704 |
133 | MP0003866_abnormal_defecation | 0.46613134 |
134 | MP0008873_increased_physiological_sensi | 0.46549728 |
135 | MP0001905_abnormal_dopamine_level | 0.45647843 |
136 | MP0009765_abnormal_xenobiotic_induced | 0.45197684 |
137 | MP0002735_abnormal_chemical_nociception | 0.45120244 |
138 | MP0004782_abnormal_surfactant_physiolog | 0.45119270 |
139 | MP0004381_abnormal_hair_follicle | 0.44935157 |
140 | MP0006035_abnormal_mitochondrial_morpho | 0.44473964 |
141 | MP0003329_amyloid_beta_deposits | 0.44330815 |
142 | MP0005195_abnormal_posterior_eye | 0.44216464 |
143 | MP0006082_CNS_inflammation | 0.43544272 |
144 | MP0001293_anophthalmia | 0.43540545 |
145 | MP0000858_altered_metastatic_potential | 0.43309502 |
146 | MP0002116_abnormal_craniofacial_bone | 0.43173878 |
147 | MP0002876_abnormal_thyroid_physiology | 0.41766778 |
148 | MP0001270_distended_abdomen | 0.41114768 |
149 | MP0002295_abnormal_pulmonary_circulatio | 0.41033991 |
150 | MP0002332_abnormal_exercise_endurance | 0.40882318 |
151 | MP0002837_dystrophic_cardiac_calcinosis | 0.40202645 |
152 | MP0005386_behavior/neurological_phenoty | 0.40139451 |
153 | MP0004924_abnormal_behavior | 0.40139451 |
154 | MP0004742_abnormal_vestibular_system | 0.40102123 |
155 | MP0003861_abnormal_nervous_system | 0.40044352 |
156 | MP0002733_abnormal_thermal_nociception | 0.39486304 |
157 | MP0005388_respiratory_system_phenotype | 0.39376998 |
158 | MP0002133_abnormal_respiratory_system | 0.39376998 |
159 | MP0004130_abnormal_muscle_cell | 0.39157138 |
160 | MP0001145_abnormal_male_reproductive | 0.38677953 |
161 | MP0003693_abnormal_embryo_hatching | 0.38382175 |
162 | MP0002066_abnormal_motor_capabilities/c | 0.37334218 |
163 | MP0009764_decreased_sensitivity_to | 0.35338746 |
164 | MP0002082_postnatal_lethality | 0.35299961 |
165 | MP0010770_preweaning_lethality | 0.35299961 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 9.60364023 |
2 | Retinal dysplasia (HP:0007973) | 8.77446435 |
3 | Abnormal respiratory motile cilium physiology (HP:0012261) | 7.10647220 |
4 | Bifid tongue (HP:0010297) | 7.00439105 |
5 | Limb dystonia (HP:0002451) | 6.33812437 |
6 | Rhinitis (HP:0012384) | 6.09862363 |
7 | Molar tooth sign on MRI (HP:0002419) | 6.07023292 |
8 | Abnormality of midbrain morphology (HP:0002418) | 6.07023292 |
9 | Abnormality of the nasal mucosa (HP:0000433) | 5.77140421 |
10 | Chronic bronchitis (HP:0004469) | 5.76836393 |
11 | Abnormality of macular pigmentation (HP:0008002) | 5.29591316 |
12 | Palpitations (HP:0001962) | 5.05529340 |
13 | Abnormal ciliary motility (HP:0012262) | 5.04696285 |
14 | Abolished electroretinogram (ERG) (HP:0000550) | 4.94850972 |
15 | Recurrent sinusitis (HP:0011108) | 4.61835557 |
16 | Dysphonia (HP:0001618) | 4.44391061 |
17 | Infertility (HP:0000789) | 4.28733455 |
18 | Abnormal respiratory motile cilium morphology (HP:0005938) | 4.17548327 |
19 | Abnormal respiratory epithelium morphology (HP:0012253) | 4.17548327 |
20 | Chronic sinusitis (HP:0011109) | 4.17329833 |
21 | Torticollis (HP:0000473) | 4.16458691 |
22 | Male infertility (HP:0003251) | 3.94457615 |
23 | Hyperglycinemia (HP:0002154) | 3.88542882 |
24 | Bony spicule pigmentary retinopathy (HP:0007737) | 3.81042621 |
25 | Craniofacial dystonia (HP:0012179) | 3.65885852 |
26 | Atonic seizures (HP:0010819) | 3.51167768 |
27 | Bronchiectasis (HP:0002110) | 3.45054844 |
28 | Focal dystonia (HP:0004373) | 3.37141002 |
29 | Gait imbalance (HP:0002141) | 3.33814616 |
30 | Congenital primary aphakia (HP:0007707) | 3.24121171 |
31 | Postaxial hand polydactyly (HP:0001162) | 3.23506674 |
32 | Occipital encephalocele (HP:0002085) | 3.18487026 |
33 | Chronic otitis media (HP:0000389) | 3.14433607 |
34 | Medial flaring of the eyebrow (HP:0010747) | 3.11196445 |
35 | Syncope (HP:0001279) | 3.09768040 |
36 | Myokymia (HP:0002411) | 3.08559890 |
37 | Pancreatic fibrosis (HP:0100732) | 3.05686560 |
38 | True hermaphroditism (HP:0010459) | 3.01697922 |
39 | Nephrogenic diabetes insipidus (HP:0009806) | 3.00207813 |
40 | Atelectasis (HP:0100750) | 2.99460015 |
41 | Renal hypoplasia (HP:0000089) | 2.96635019 |
42 | Short nail (HP:0001799) | 2.92354299 |
43 | Poikilocytosis (HP:0004447) | 2.88876504 |
44 | Hyperactive renin-angiotensin system (HP:0000841) | 2.86345152 |
45 | Oculomotor apraxia (HP:0000657) | 2.78980368 |
46 | Hypothermia (HP:0002045) | 2.76697730 |
47 | Cystic liver disease (HP:0006706) | 2.69967687 |
48 | Abnormality of dentin (HP:0010299) | 2.69567802 |
49 | Prolonged QT interval (HP:0001657) | 2.64951250 |
50 | Abnormality of sodium homeostasis (HP:0010931) | 2.64709742 |
51 | Chronic hepatic failure (HP:0100626) | 2.63742073 |
52 | Febrile seizures (HP:0002373) | 2.63265567 |
53 | Pancreatic cysts (HP:0001737) | 2.59482503 |
54 | Neuroendocrine neoplasm (HP:0100634) | 2.52283776 |
55 | Vacuolated lymphocytes (HP:0001922) | 2.49909132 |
56 | Vaginal atresia (HP:0000148) | 2.46027151 |
57 | Poor coordination (HP:0002370) | 2.44762649 |
58 | Abnormal biliary tract physiology (HP:0012439) | 2.42386832 |
59 | Bile duct proliferation (HP:0001408) | 2.42386832 |
60 | Postaxial foot polydactyly (HP:0001830) | 2.39215429 |
61 | Hyperglycinuria (HP:0003108) | 2.34130974 |
62 | Genital tract atresia (HP:0001827) | 2.30530685 |
63 | Constricted visual fields (HP:0001133) | 2.26961057 |
64 | Supernumerary spleens (HP:0009799) | 2.26935838 |
65 | Anosmia (HP:0000458) | 2.25295853 |
66 | Recurrent otitis media (HP:0000403) | 2.21529265 |
67 | Nephronophthisis (HP:0000090) | 2.21329597 |
68 | Restlessness (HP:0000711) | 2.18468115 |
69 | Absence seizures (HP:0002121) | 2.14254843 |
70 | Bronchitis (HP:0012387) | 2.05930132 |
71 | Sensory axonal neuropathy (HP:0003390) | 2.05923832 |
72 | Recurrent bronchitis (HP:0002837) | 2.02420356 |
73 | Narrow forehead (HP:0000341) | 2.00681879 |
74 | Anencephaly (HP:0002323) | 1.99070302 |
75 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.97819913 |
76 | Abnormality of glycine metabolism (HP:0010895) | 1.97819913 |
77 | Bell-shaped thorax (HP:0001591) | 1.96666612 |
78 | Congenital hepatic fibrosis (HP:0002612) | 1.95551502 |
79 | Furrowed tongue (HP:0000221) | 1.91650195 |
80 | Tubulointerstitial nephritis (HP:0001970) | 1.90585627 |
81 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.90542648 |
82 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.89557536 |
83 | Complete atrioventricular canal defect (HP:0001674) | 1.87975397 |
84 | Severe visual impairment (HP:0001141) | 1.87751742 |
85 | Absent/shortened dynein arms (HP:0200106) | 1.87193719 |
86 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.87193719 |
87 | Absent frontal sinuses (HP:0002688) | 1.84093795 |
88 | Male pseudohermaphroditism (HP:0000037) | 1.83635707 |
89 | Agitation (HP:0000713) | 1.82952115 |
90 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.82241033 |
91 | Retinitis pigmentosa (HP:0000510) | 1.81336687 |
92 | Abnormality of the dental root (HP:0006486) | 1.80713777 |
93 | Taurodontia (HP:0000679) | 1.80713777 |
94 | Abnormality of permanent molar morphology (HP:0011071) | 1.80713777 |
95 | Primary atrial arrhythmia (HP:0001692) | 1.80134793 |
96 | Focal seizures (HP:0007359) | 1.77294535 |
97 | Aganglionic megacolon (HP:0002251) | 1.76869927 |
98 | Decreased circulating renin level (HP:0003351) | 1.74258198 |
99 | Supraventricular tachycardia (HP:0004755) | 1.73582439 |
100 | Abnormality of the phalanges of the hallux (HP:0010057) | 1.73367735 |
101 | Nasal polyposis (HP:0100582) | 1.73079298 |
102 | Abnormality of alanine metabolism (HP:0010916) | 1.72958472 |
103 | Hyperalaninemia (HP:0003348) | 1.72958472 |
104 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.72958472 |
105 | Asplenia (HP:0001746) | 1.71948189 |
106 | Abnormality of molar morphology (HP:0011070) | 1.71361866 |
107 | Abnormality of molar (HP:0011077) | 1.71361866 |
108 | Renal salt wasting (HP:0000127) | 1.71145571 |
109 | Hydroureter (HP:0000072) | 1.70376687 |
110 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.69056895 |
111 | Abnormality of the renal medulla (HP:0100957) | 1.67997485 |
112 | Supraventricular arrhythmia (HP:0005115) | 1.67105188 |
113 | Acute encephalopathy (HP:0006846) | 1.66386950 |
114 | Hyperventilation (HP:0002883) | 1.66106378 |
115 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.64701064 |
116 | Atrial fibrillation (HP:0005110) | 1.64297794 |
117 | Tubular atrophy (HP:0000092) | 1.64098013 |
118 | Abnormality of the vocal cords (HP:0008777) | 1.63834223 |
119 | Sudden death (HP:0001699) | 1.63729748 |
120 | Nephropathy (HP:0000112) | 1.63334976 |
121 | Hyperkalemia (HP:0002153) | 1.61438482 |
122 | Sclerocornea (HP:0000647) | 1.58829514 |
123 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.44514926 |
124 | Hyperaldosteronism (HP:0000859) | 1.44058957 |
125 | Hand muscle atrophy (HP:0009130) | 1.38732824 |
126 | Abnormality of renin-angiotensin system (HP:0000847) | 1.28265095 |
127 | Tubulointerstitial abnormality (HP:0001969) | 1.27708471 |
128 | Glucose intolerance (HP:0000833) | 1.27608314 |
129 | Abnormality of chloride homeostasis (HP:0011422) | 1.27256893 |
130 | Preaxial hand polydactyly (HP:0001177) | 1.26997358 |
131 | Stage 5 chronic kidney disease (HP:0003774) | 1.22609806 |
132 | Median cleft lip (HP:0000161) | 1.21025298 |
133 | Short thorax (HP:0010306) | 1.20950409 |
134 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.20147516 |
135 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.16918938 |
136 | Hypokalemic alkalosis (HP:0001949) | 1.16342964 |
137 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.15581666 |
138 | Abnormality of the frontal sinuses (HP:0002687) | 1.14526806 |
139 | Bifid scrotum (HP:0000048) | 1.13877415 |
140 | Abnormality of the dental pulp (HP:0006479) | 1.12011619 |
141 | Cone-rod dystrophy (HP:0000548) | 1.11673815 |
142 | Hyponatremia (HP:0002902) | 1.10965786 |
143 | Muscle fiber splitting (HP:0003555) | 1.05118259 |
144 | Decreased central vision (HP:0007663) | 1.04727559 |
145 | Fetal akinesia sequence (HP:0001989) | 1.03785705 |
146 | Obstructive sleep apnea (HP:0002870) | 1.02895566 |
147 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.00862014 |
148 | Polydipsia (HP:0001959) | 1.00467101 |
149 | Abnormal drinking behavior (HP:0030082) | 1.00467101 |
150 | Upper limb amyotrophy (HP:0009129) | 0.99888880 |
151 | Distal upper limb amyotrophy (HP:0007149) | 0.99888880 |
152 | Aplasia of the musculature (HP:0100854) | 0.94558489 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MST4 | 5.79462781 |
2 | EPHA2 | 4.92529901 |
3 | PHKG2 | 4.56278725 |
4 | PHKG1 | 4.56278725 |
5 | TRIB3 | 4.34338481 |
6 | CAMK2B | 3.18773127 |
7 | CAMK2D | 3.05048452 |
8 | DAPK2 | 2.87292946 |
9 | ARAF | 2.78907847 |
10 | CAMK2G | 2.71673069 |
11 | MAP3K2 | 2.59971087 |
12 | LATS1 | 2.58845637 |
13 | ERBB3 | 2.52780892 |
14 | CAMKK2 | 2.49765660 |
15 | ICK | 2.45910141 |
16 | CAMK1D | 2.43951571 |
17 | CAMK1G | 2.39432953 |
18 | ILK | 2.38109950 |
19 | PAK3 | 2.37754703 |
20 | NME1 | 2.28379246 |
21 | MAPK15 | 2.24448683 |
22 | SMG1 | 2.17804513 |
23 | CSNK1A1L | 1.95241900 |
24 | STK24 | 1.91366800 |
25 | NUAK1 | 1.81936933 |
26 | STK38L | 1.76561374 |
27 | CSNK1G3 | 1.70141772 |
28 | CSNK1G2 | 1.61923119 |
29 | RIPK4 | 1.55090607 |
30 | MAP2K7 | 1.49303057 |
31 | MAP3K3 | 1.48791079 |
32 | CSK | 1.45557896 |
33 | MAP3K7 | 1.43163910 |
34 | STK10 | 1.36951190 |
35 | PRKCG | 1.36624019 |
36 | CSNK1G1 | 1.32499258 |
37 | DYRK1B | 1.32238541 |
38 | CAMKK1 | 1.25879397 |
39 | BCR | 1.24538060 |
40 | NEK6 | 1.20451890 |
41 | EPHB1 | 1.20265896 |
42 | LATS2 | 1.19923938 |
43 | EEF2K | 1.19675575 |
44 | IRAK1 | 1.17026850 |
45 | IRAK2 | 1.16238894 |
46 | LRRK2 | 1.12731403 |
47 | MST1R | 1.12404242 |
48 | CAMK2A | 1.11610991 |
49 | STK38 | 1.09919807 |
50 | DAPK1 | 1.03685512 |
51 | RPS6KA2 | 1.01232889 |
52 | GRK6 | 1.01069445 |
53 | MAPKAPK3 | 0.98956388 |
54 | PNCK | 0.98637592 |
55 | MAP3K4 | 0.97691659 |
56 | PIM2 | 0.92653139 |
57 | NLK | 0.90019953 |
58 | PRKCI | 0.86818695 |
59 | TBK1 | 0.82287012 |
60 | TESK1 | 0.82083680 |
61 | MARK2 | 0.81877684 |
62 | FRK | 0.80418262 |
63 | CAMK1 | 0.79187536 |
64 | PRKD2 | 0.73567286 |
65 | BMPR2 | 0.72471696 |
66 | CAMK4 | 0.72350450 |
67 | PRKG2 | 0.71482058 |
68 | BRAF | 0.71340520 |
69 | GRK5 | 0.69890307 |
70 | EPHA3 | 0.69817668 |
71 | TLK1 | 0.69462161 |
72 | TTK | 0.69461628 |
73 | MAPK7 | 0.68876192 |
74 | PLK2 | 0.67992864 |
75 | MAP3K12 | 0.67905409 |
76 | RPS6KA4 | 0.66595839 |
77 | MUSK | 0.64040954 |
78 | RIPK1 | 0.63484812 |
79 | ACVR1B | 0.63167000 |
80 | TXK | 0.60403303 |
81 | MINK1 | 0.59062123 |
82 | HIPK2 | 0.58594418 |
83 | NEK9 | 0.56236718 |
84 | CDK5 | 0.56184886 |
85 | PKN1 | 0.55919922 |
86 | DAPK3 | 0.54881776 |
87 | SIK2 | 0.54695918 |
88 | PRKAA2 | 0.53903965 |
89 | STK39 | 0.51736308 |
90 | MARK1 | 0.51357854 |
91 | CDK3 | 0.50628742 |
92 | STK11 | 0.49554618 |
93 | MELK | 0.49506537 |
94 | CDK19 | 0.48840434 |
95 | ERBB2 | 0.46810081 |
96 | AURKA | 0.46292348 |
97 | CASK | 0.45891751 |
98 | TNIK | 0.44520607 |
99 | MAP2K4 | 0.43804683 |
100 | MAP2K2 | 0.43159829 |
101 | MAP3K6 | 0.42054334 |
102 | PRKCQ | 0.41903070 |
103 | PRKD3 | 0.41880664 |
104 | BRSK2 | 0.41180821 |
105 | ROCK2 | 0.41057389 |
106 | FER | 0.40197157 |
107 | PRKCD | 0.38520915 |
108 | CCNB1 | 0.36967531 |
109 | SGK1 | 0.36318670 |
110 | DYRK3 | 0.35469974 |
111 | MAPK11 | 0.33772658 |
112 | TAOK1 | 0.33290845 |
113 | PTK2B | 0.33288549 |
114 | DYRK1A | 0.33005656 |
115 | AKT3 | 0.32739835 |
116 | KSR2 | 0.32317654 |
117 | NTRK2 | 0.31184259 |
118 | AKT2 | 0.31017286 |
119 | PRKACA | 0.30695650 |
120 | PRKD1 | 0.30613346 |
121 | RET | 0.30113867 |
122 | ADRBK1 | 0.29789477 |
123 | PAK4 | 0.29595504 |
124 | STK16 | 0.29306368 |
125 | TRPM7 | 0.28706764 |
126 | SGK223 | 0.27916500 |
127 | SGK494 | 0.27916500 |
128 | OXSR1 | 0.27419335 |
129 | PAK6 | 0.27395980 |
130 | CDC42BPA | 0.27381989 |
131 | PRKAA1 | 0.27291709 |
132 | MET | 0.27128850 |
133 | FYN | 0.26690989 |
134 | PRKACG | 0.26560235 |
135 | PRKCZ | 0.26162387 |
136 | PDPK1 | 0.26111857 |
137 | PLK1 | 0.25862700 |
138 | EPHA4 | 0.25329025 |
139 | LMTK2 | 0.23827109 |
140 | ABL1 | 0.23376374 |
141 | CSNK1E | 0.23371729 |
142 | PRKCA | 0.23302044 |
143 | PDK1 | 0.22684152 |
144 | BMPR1B | 0.22627656 |
145 | ERBB4 | 0.22295273 |
146 | TYK2 | 0.21122792 |
147 | MAP2K1 | 0.20947129 |
148 | MOS | 0.20431166 |
149 | MAPK10 | 0.20214353 |
150 | PAK1 | 0.18921070 |
151 | STK3 | 0.18707154 |
152 | ZAP70 | 0.14226235 |
153 | PTK6 | 0.13643501 |
154 | RPS6KB2 | 0.13409649 |
155 | CHEK2 | 0.13385198 |
156 | FGFR3 | 0.12645728 |
157 | ROCK1 | 0.12260257 |
158 | PASK | 0.12223396 |
159 | SRC | 0.11583104 |
160 | MAP3K8 | 0.10968035 |
161 | CDK6 | 0.10127890 |
162 | MAPKAPK5 | 0.09163214 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 5.58896412 |
2 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 5.40434938 |
3 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 4.45330551 |
4 | Tyrosine metabolism_Homo sapiens_hsa00350 | 3.96519670 |
5 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 2.84906083 |
6 | Glutathione metabolism_Homo sapiens_hsa00480 | 2.67376003 |
7 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.17451537 |
8 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.16221284 |
9 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.12850362 |
10 | Retinol metabolism_Homo sapiens_hsa00830 | 2.07577401 |
11 | * Olfactory transduction_Homo sapiens_hsa04740 | 11.3915645 |
12 | Phototransduction_Homo sapiens_hsa04744 | 1.96319319 |
13 | Morphine addiction_Homo sapiens_hsa05032 | 1.87542140 |
14 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.83848714 |
15 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.77168361 |
16 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.72506164 |
17 | Insulin secretion_Homo sapiens_hsa04911 | 1.71227868 |
18 | Circadian entrainment_Homo sapiens_hsa04713 | 1.70614270 |
19 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.66122709 |
20 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.63877204 |
21 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.60331525 |
22 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.55124911 |
23 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.50742570 |
24 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.50148015 |
25 | Taste transduction_Homo sapiens_hsa04742 | 1.48411715 |
26 | Bile secretion_Homo sapiens_hsa04976 | 1.48134682 |
27 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.48117220 |
28 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.47627648 |
29 | Salivary secretion_Homo sapiens_hsa04970 | 1.47469460 |
30 | GABAergic synapse_Homo sapiens_hsa04727 | 1.45382868 |
31 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.45226232 |
32 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.40043241 |
33 | Tight junction_Homo sapiens_hsa04530 | 1.37554446 |
34 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.35635364 |
35 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.34016690 |
36 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.29285980 |
37 | * cAMP signaling pathway_Homo sapiens_hsa04024 | 1.28665719 |
38 | Histidine metabolism_Homo sapiens_hsa00340 | 1.24528529 |
39 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.23669910 |
40 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.13716945 |
41 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.05923365 |
42 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.01692203 |
43 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.99151803 |
44 | Gap junction_Homo sapiens_hsa04540 | 0.98161260 |
45 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.97953306 |
46 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.97715191 |
47 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.96560224 |
48 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.90947971 |
49 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.90879787 |
50 | Alcoholism_Homo sapiens_hsa05034 | 0.81619595 |
51 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.80997480 |
52 | Parkinsons disease_Homo sapiens_hsa05012 | 0.80398442 |
53 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.79388699 |
54 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.78628719 |
55 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.78586382 |
56 | Adherens junction_Homo sapiens_hsa04520 | 0.76648830 |
57 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.75328779 |
58 | Melanogenesis_Homo sapiens_hsa04916 | 0.75263488 |
59 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.71667527 |
60 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.68810413 |
61 | Hepatitis C_Homo sapiens_hsa05160 | 0.68607076 |
62 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.68416117 |
63 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.66955872 |
64 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.66479976 |
65 | Circadian rhythm_Homo sapiens_hsa04710 | 0.66175177 |
66 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.66113633 |
67 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.64990224 |
68 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.64910814 |
69 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.64872302 |
70 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.64652022 |
71 | Renin secretion_Homo sapiens_hsa04924 | 0.63500933 |
72 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.63366515 |
73 | Cocaine addiction_Homo sapiens_hsa05030 | 0.61439717 |
74 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.60387654 |
75 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.59972208 |
76 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.58458758 |
77 | Long-term potentiation_Homo sapiens_hsa04720 | 0.58251619 |
78 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.56443837 |
79 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.55382187 |
80 | ABC transporters_Homo sapiens_hsa02010 | 0.55379087 |
81 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.55087141 |
82 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.53979090 |
83 | Other glycan degradation_Homo sapiens_hsa00511 | 0.53887689 |
84 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.52740341 |
85 | Purine metabolism_Homo sapiens_hsa00230 | 0.52148572 |
86 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.50984704 |
87 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.50594760 |
88 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.50019251 |
89 | Nicotine addiction_Homo sapiens_hsa05033 | 0.48621215 |
90 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.48291654 |
91 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.45901423 |
92 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.44517806 |
93 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.44028954 |
94 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.43726466 |
95 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.43303238 |
96 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.42312999 |
97 | Alzheimers disease_Homo sapiens_hsa05010 | 0.42169405 |
98 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.41712786 |
99 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.39874450 |
100 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.38798280 |
101 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.38334725 |
102 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.38163703 |
103 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.35641565 |
104 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.34673287 |
105 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.32955230 |
106 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.32492939 |
107 | Lysosome_Homo sapiens_hsa04142 | 0.32014588 |
108 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.31734783 |
109 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.31720904 |
110 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.30672952 |
111 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.30621217 |
112 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.30602208 |
113 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.30385058 |
114 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.30328294 |
115 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.28884807 |
116 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.28539863 |
117 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.28309430 |
118 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.27635609 |
119 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.27385100 |
120 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.27236223 |
121 | Allograft rejection_Homo sapiens_hsa05330 | 0.26911139 |
122 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.25207445 |
123 | Axon guidance_Homo sapiens_hsa04360 | 0.25116218 |
124 | Amoebiasis_Homo sapiens_hsa05146 | 0.24726548 |
125 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.24518442 |
126 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.23710823 |
127 | Glioma_Homo sapiens_hsa05214 | 0.23036267 |
128 | Metabolic pathways_Homo sapiens_hsa01100 | 0.22798021 |
129 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.22769681 |
130 | Huntingtons disease_Homo sapiens_hsa05016 | 0.22312001 |
131 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.21131130 |
132 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.20727579 |
133 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.20494460 |
134 | Peroxisome_Homo sapiens_hsa04146 | 0.20443386 |
135 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.20081872 |
136 | Phagosome_Homo sapiens_hsa04145 | 0.19030940 |
137 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.18998809 |
138 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.18372017 |
139 | Asthma_Homo sapiens_hsa05310 | 0.18251979 |
140 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.17818639 |
141 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.17115932 |
142 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.16861052 |
143 | Carbon metabolism_Homo sapiens_hsa01200 | 0.16626239 |
144 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.15880807 |
145 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.15472517 |
146 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.15377105 |
147 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.15373683 |
148 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.15239394 |
149 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.15117826 |
150 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.14244814 |
151 | Endocytosis_Homo sapiens_hsa04144 | 0.13886098 |
152 | Insulin resistance_Homo sapiens_hsa04931 | 0.13044637 |
153 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.12802517 |
154 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.11900692 |
155 | Viral myocarditis_Homo sapiens_hsa05416 | 0.11419780 |
156 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.11352765 |
157 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.10225841 |
158 | Prostate cancer_Homo sapiens_hsa05215 | 0.08376390 |
159 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.07595854 |
160 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.07166124 |
161 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.06928825 |
162 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.06429442 |